Acetylenic Synthetic Betulin Derivatives Inhibit Akt and Erk Kinases Activity, Trigger Apoptosis and Suppress Proliferation of Neuroblastoma and Rhabdomyosarcoma Cell Lines

Neuroblastoma (NB) and rhabdomyosarcoma (RMS), the most common pediatric extracranial solid tumors, still represent an important clinical challenge since no effective treatment is available for metastatic and recurrent disease. Hence, there is an urgent need for the development of new chemotherapeut...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sylwia K. Król, Ewa Bębenek, Magdalena Dmoszyńska-Graniczka, Adrianna Sławińska-Brych, Stanisław Boryczka, Andrzej Stepulak
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/ba5e1d6c4a214d36af98357814decfc0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ba5e1d6c4a214d36af98357814decfc0
record_format dspace
spelling oai:doaj.org-article:ba5e1d6c4a214d36af98357814decfc02021-11-25T17:55:11ZAcetylenic Synthetic Betulin Derivatives Inhibit Akt and Erk Kinases Activity, Trigger Apoptosis and Suppress Proliferation of Neuroblastoma and Rhabdomyosarcoma Cell Lines10.3390/ijms2222122991422-00671661-6596https://doaj.org/article/ba5e1d6c4a214d36af98357814decfc02021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/22/12299https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Neuroblastoma (NB) and rhabdomyosarcoma (RMS), the most common pediatric extracranial solid tumors, still represent an important clinical challenge since no effective treatment is available for metastatic and recurrent disease. Hence, there is an urgent need for the development of new chemotherapeutics to improve the outcome of patients. Betulin (Bet), a triterpenoid from the bark of birches, demonstrated interesting anti-cancer potential. The modification of natural phytochemicals with evidenced anti-tumor activity, including Bet, is one of the methods of receiving new compounds for potential implementation in oncological treatment. Here, we showed that two acetylenic synthetic Bet derivatives (ASBDs), EB5 and EB25/1, reduced the viability and proliferation of SK-N-AS and TE671 cells, as measured by MTT and BrdU tests, respectively. Moreover, ASBDs were also more cytotoxic than temozolomide (TMZ) and cisplatin (cis-diaminedichloroplatinum [II], CDDP) in vitro, and the combination of EB5 with CDDP enhanced anti-cancer effects. We also showed the slowdown of cell cycle progression at S/G<sub>2</sub> phases mediated by EB5 using FACS flow cytometry. The decreased viability and proliferation of pediatric cancers cells after treatment with ASBDs was linked to the reduced activity of kinases Akt, Erk1/2 and p38 and the induction of apoptosis, as investigated using Western blotting and FACS. In addition, in silico analyses of the ADMET profile found EB5 to be a promising anti-cancer drug candidate that would benefit from further investigation.Sylwia K. KrólEwa BębenekMagdalena Dmoszyńska-GraniczkaAdrianna Sławińska-BrychStanisław BoryczkaAndrzej StepulakMDPI AGarticleacetylenic synthetic betulin derivativesADMETbetulinchemotherapycisplatindruglikenessBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 12299, p 12299 (2021)
institution DOAJ
collection DOAJ
language EN
topic acetylenic synthetic betulin derivatives
ADMET
betulin
chemotherapy
cisplatin
druglikeness
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle acetylenic synthetic betulin derivatives
ADMET
betulin
chemotherapy
cisplatin
druglikeness
Biology (General)
QH301-705.5
Chemistry
QD1-999
Sylwia K. Król
Ewa Bębenek
Magdalena Dmoszyńska-Graniczka
Adrianna Sławińska-Brych
Stanisław Boryczka
Andrzej Stepulak
Acetylenic Synthetic Betulin Derivatives Inhibit Akt and Erk Kinases Activity, Trigger Apoptosis and Suppress Proliferation of Neuroblastoma and Rhabdomyosarcoma Cell Lines
description Neuroblastoma (NB) and rhabdomyosarcoma (RMS), the most common pediatric extracranial solid tumors, still represent an important clinical challenge since no effective treatment is available for metastatic and recurrent disease. Hence, there is an urgent need for the development of new chemotherapeutics to improve the outcome of patients. Betulin (Bet), a triterpenoid from the bark of birches, demonstrated interesting anti-cancer potential. The modification of natural phytochemicals with evidenced anti-tumor activity, including Bet, is one of the methods of receiving new compounds for potential implementation in oncological treatment. Here, we showed that two acetylenic synthetic Bet derivatives (ASBDs), EB5 and EB25/1, reduced the viability and proliferation of SK-N-AS and TE671 cells, as measured by MTT and BrdU tests, respectively. Moreover, ASBDs were also more cytotoxic than temozolomide (TMZ) and cisplatin (cis-diaminedichloroplatinum [II], CDDP) in vitro, and the combination of EB5 with CDDP enhanced anti-cancer effects. We also showed the slowdown of cell cycle progression at S/G<sub>2</sub> phases mediated by EB5 using FACS flow cytometry. The decreased viability and proliferation of pediatric cancers cells after treatment with ASBDs was linked to the reduced activity of kinases Akt, Erk1/2 and p38 and the induction of apoptosis, as investigated using Western blotting and FACS. In addition, in silico analyses of the ADMET profile found EB5 to be a promising anti-cancer drug candidate that would benefit from further investigation.
format article
author Sylwia K. Król
Ewa Bębenek
Magdalena Dmoszyńska-Graniczka
Adrianna Sławińska-Brych
Stanisław Boryczka
Andrzej Stepulak
author_facet Sylwia K. Król
Ewa Bębenek
Magdalena Dmoszyńska-Graniczka
Adrianna Sławińska-Brych
Stanisław Boryczka
Andrzej Stepulak
author_sort Sylwia K. Król
title Acetylenic Synthetic Betulin Derivatives Inhibit Akt and Erk Kinases Activity, Trigger Apoptosis and Suppress Proliferation of Neuroblastoma and Rhabdomyosarcoma Cell Lines
title_short Acetylenic Synthetic Betulin Derivatives Inhibit Akt and Erk Kinases Activity, Trigger Apoptosis and Suppress Proliferation of Neuroblastoma and Rhabdomyosarcoma Cell Lines
title_full Acetylenic Synthetic Betulin Derivatives Inhibit Akt and Erk Kinases Activity, Trigger Apoptosis and Suppress Proliferation of Neuroblastoma and Rhabdomyosarcoma Cell Lines
title_fullStr Acetylenic Synthetic Betulin Derivatives Inhibit Akt and Erk Kinases Activity, Trigger Apoptosis and Suppress Proliferation of Neuroblastoma and Rhabdomyosarcoma Cell Lines
title_full_unstemmed Acetylenic Synthetic Betulin Derivatives Inhibit Akt and Erk Kinases Activity, Trigger Apoptosis and Suppress Proliferation of Neuroblastoma and Rhabdomyosarcoma Cell Lines
title_sort acetylenic synthetic betulin derivatives inhibit akt and erk kinases activity, trigger apoptosis and suppress proliferation of neuroblastoma and rhabdomyosarcoma cell lines
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/ba5e1d6c4a214d36af98357814decfc0
work_keys_str_mv AT sylwiakkrol acetylenicsyntheticbetulinderivativesinhibitaktanderkkinasesactivitytriggerapoptosisandsuppressproliferationofneuroblastomaandrhabdomyosarcomacelllines
AT ewabebenek acetylenicsyntheticbetulinderivativesinhibitaktanderkkinasesactivitytriggerapoptosisandsuppressproliferationofneuroblastomaandrhabdomyosarcomacelllines
AT magdalenadmoszynskagraniczka acetylenicsyntheticbetulinderivativesinhibitaktanderkkinasesactivitytriggerapoptosisandsuppressproliferationofneuroblastomaandrhabdomyosarcomacelllines
AT adriannasławinskabrych acetylenicsyntheticbetulinderivativesinhibitaktanderkkinasesactivitytriggerapoptosisandsuppressproliferationofneuroblastomaandrhabdomyosarcomacelllines
AT stanisławboryczka acetylenicsyntheticbetulinderivativesinhibitaktanderkkinasesactivitytriggerapoptosisandsuppressproliferationofneuroblastomaandrhabdomyosarcomacelllines
AT andrzejstepulak acetylenicsyntheticbetulinderivativesinhibitaktanderkkinasesactivitytriggerapoptosisandsuppressproliferationofneuroblastomaandrhabdomyosarcomacelllines
_version_ 1718411883644452864